madeolz.blogg.se

It challenges the reasons why people smoke, and most people report that they not only stop smoking, but actually lose the desire to smoke.

The Allen Carr‘s Easyway to Stop Smoking Seminar Programme does not rely on any nicotine, nicotine substances, patches or other pharmaceuticals. It is believed that this is the first time that such a therapy has been subjected to the rigours of a full RCT. ‘After this trial, I can now recommend Allen Carr treatment and can recommend it to the government if they ask for advice. Professor Luke Clancy, a founder and director general of The Tobacco Free Research Institute Ireland, said that the results mean he can now tell patients to use the Allen Carr method. Working together, we can now provide a realistic and more cost-effective opportunity to free Australia of smoking – which was the reason that the Irish Government’s Minister for Health pushed so strongly for the study to happen.” “These results should give the Australian Government the confidence to make Allen Carr’s Easyway to Stop Smoking Seminar programme available as an exciting alternative to nicotine patches, nicotine gum, and other publicly funded treatments in Australia. Natalie Clays, Allen Carr’s Easyway Australia’s Managing Director said: The results of the trial show that Allen Carr’s Easyway quit rates were ALWAYS superior to Quit.ie, consistently achieving higher quit rates at 1, 3, 6 and 12 months. This should pave the way for this drug-free, quick & easy method to be made available via the Irish Health Service and the NHS.” We are also expecting the findings of a London-based RCT to be published soon, which should confirm that Allen Carr’s Easyway method is better than, or at least as good as, the current gold standard One-to-One NHS Stop Smoking Service. There is no doubt that being a cognitive (spoken) method doesn’t make it particularly suitable for this kind of clinical trial but even in these circumstances we’re delighted that the method was found to be twice effective as the current treatments available in Ireland. “This is a landmark day as, for the first time, it presents the results of the programme’s performance in a robust clinical trial. John Dicey, Global CEO of Allen Carr’s Easyway comments: The trial results have been reported in the BMJ’s Tobacco Control Journal on 26 October 2018, which can be found here: The leading stop smoking treatment, Allen Carr’s Easyway to Stop Smoking Seminars, which is completely drug free, has today received a major boost.Ī fully independent Randomised Control Trial (RCT), conducted on behalf of the Irish Government, has found that it is twice as effective as the techniques currently offered by the Irish Health Service (which include nicotine patches, e-cigarettes and gum). Allen Carr is now a proven, effective, drug-free alternative to nicotine patches, nicotine gum, and e-cigarettes potentially taking the treatment of smokers out of the hands of Big Tobacco & Big Pharma for the first time.